FdaApplication

NDA 210833

Back to search

Identifiers

Properties

PropertyValue
applicant_nameCOSETTE PHARMACEUTICALS INC
application_typeNDA
approval_date2018-11-01

Products (3)

ProductActive ingredientStrengthDosage form
SYMPAZANCLOBAZAM10MGFILM;ORAL
SYMPAZANCLOBAZAM5MGFILM;ORAL
SYMPAZANCLOBAZAM20MGFILM;ORAL

3 products